Cannabis in Medicine 2020
DOI: 10.1007/978-3-030-45968-0_8
|View full text |Cite
|
Sign up to set email alerts
|

Cannabis in Pulmonary Medicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 69 publications
0
1
0
Order By: Relevance
“…7,8 Smoking marijuana exposes the lungs to toxic combustion products that can trigger various respiratory issues such as asthma, pneumonia, emphysema, and chronic obstructive pulmonary disease. 9,10,11,12 Moreover, recent trends in vaping, e-cigarettes, and alternative forms of cannabis consumption have revealed damage to lung histology and blood vessels. 13,14 Furthermore, potential health risks are associated with THC additives and oils used in smoking, and the development of new ingredients for cannabis vaporizers, such as Vitamin E, Δ8-tetrahydrocannabinol, Δ10-tetrahydrocannabinol, hexahydrocannabinol, and cannabichromene, continues to increase.…”
Section: Introductionmentioning
confidence: 99%
“…7,8 Smoking marijuana exposes the lungs to toxic combustion products that can trigger various respiratory issues such as asthma, pneumonia, emphysema, and chronic obstructive pulmonary disease. 9,10,11,12 Moreover, recent trends in vaping, e-cigarettes, and alternative forms of cannabis consumption have revealed damage to lung histology and blood vessels. 13,14 Furthermore, potential health risks are associated with THC additives and oils used in smoking, and the development of new ingredients for cannabis vaporizers, such as Vitamin E, Δ8-tetrahydrocannabinol, Δ10-tetrahydrocannabinol, hexahydrocannabinol, and cannabichromene, continues to increase.…”
Section: Introductionmentioning
confidence: 99%